294 related articles for article (PubMed ID: 28584279)
1. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
Zhou J; Song L; Zhao H; Yan L; Ma A; Xie S; Zhang X; Zhang D; Xie Q; Zhang G; Shang J; Cheng J; Zhao W; Zou Z; Zhang M; Xia N; Wang G
Sci Rep; 2017 Jun; 7(1):2747. PubMed ID: 28584279
[TBL] [Abstract][Full Text] [Related]
2. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
3. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
Yao K; Wang J; Wang L; Xia J; Yan X; Wu W; Liu J; Wang L; Yin S; Tong X; Ding W; Huang R; Wu C
J Med Virol; 2022 Feb; 94(2):659-666. PubMed ID: 34499353
[TBL] [Abstract][Full Text] [Related]
4. Prediction model for sustained hepatitis B e antigen seroconversion to peginterferon alfa-2a in chronic hepatitis B.
Zhu H; Wang C; Zhang Y; Wei S; Li X; Zhang Z
J Gastroenterol Hepatol; 2016 Dec; 31(12):1963-1970. PubMed ID: 27075693
[TBL] [Abstract][Full Text] [Related]
5. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
6. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
7. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of hepatitis B core antibody level in the natural history of chronic hepatitis B.
Wang J; Yan X; Chen Y; Liu Y; Wang L; Jia B; Wang G; Xiong Y; Song P; Wu W; Xia J; Lu S; Zhang Z; Huang R; Wu C
Discov Med; 2018 Oct; 26(143):119-125. PubMed ID: 30586535
[TBL] [Abstract][Full Text] [Related]
9. Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients.
Wang CT; Zhang YF; Sun BH; Dai Y; Zhu HL; Xu YH; Lu MJ; Yang DL; Li X; Zhang ZH
World J Gastroenterol; 2015 May; 21(18):5668-76. PubMed ID: 25987794
[TBL] [Abstract][Full Text] [Related]
10. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
Chen HS; Wu JF; Su TH; Chen HL; Hsu HY; Xia NS; Chen PJ; Chang MH
Hepatology; 2019 Dec; 70(6):1903-1912. PubMed ID: 31121067
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
[TBL] [Abstract][Full Text] [Related]
13. Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment.
Zhao XA; Wang J; Liu J; Chen G; Yan X; Jia B; Yang Y; Liu Y; Gu D; Zhang Z; Xiang X; Huang R; Wu C
Antiviral Res; 2021 Sep; 193():105146. PubMed ID: 34314774
[TBL] [Abstract][Full Text] [Related]
14. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
15. Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study.
Jia W; Song LW; Fang YQ; Wu XF; Liu DY; Xu C; Wang XM; Wang W; Lv DX; Li J; Deng YQ; Wang Y; Huo N; Yu M; Xi HL; Liu D; Zhou YX; Wang GQ; Xia NS; Zhang MX
Medicine (Baltimore); 2014 Dec; 93(29):e322. PubMed ID: 25546679
[TBL] [Abstract][Full Text] [Related]
16. Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir.
Wang CC; Tseng KC; Peng CY; Hsieh TY; Lin CL; Su TH; Tseng TC; Hsu CS; Lin HH; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):46-50. PubMed ID: 22989322
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.
Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D
Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941
[TBL] [Abstract][Full Text] [Related]
18. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm.
Zhou JY; Song LW; Yuan R; Lu XP; Wang GQ
World J Gastroenterol; 2021 Jun; 27(21):2910-2920. PubMed ID: 34135561
[TBL] [Abstract][Full Text] [Related]
19. Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients.
Wang X; Gao X; Wu R; Chi X; Xu H; Guan Y; Jin Q; Niu J
J Gastroenterol Hepatol; 2022 Sep; 37(9):1806-1814. PubMed ID: 35509262
[TBL] [Abstract][Full Text] [Related]
20. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
Li J; Sun X; Fang J; Wang C; Han G; Ren W
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
